(Q46887058)

26 December 2017

title

Hyperglycaemia acutely decreases circulating dehydroepiandrosterone levels in healthy men. (English)

1 reference

26 December 2017

1 reference

1 reference

26 December 2017

author name string

Boudou P

1 reference

26 December 2017

Sobngwi E

1 reference

26 December 2017

Ibrahim F

1 reference

26 December 2017

Vexiau P

1 reference

26 December 2017

Calvo F

1 reference

26 December 2017

Gautier JF

1 reference

26 December 2017

publication date

1 January 2006

1 reference

26 December 2017

published in

Clinical Endocrinology

1 reference

26 December 2017

volume

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

46-52

1 reference

26 December 2017

Dehydroepiandrosterone replacement therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

DHEA treatment: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Serum concentrations of delta 5-3 beta-hydroxysteroids in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Reduced testosterone and adrenal C19 steroid levels in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Insulin inhibits adrenal 17,20-lyase activity in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Relationships between age, dehydro-epiandrosterone sulphate and plasma glucose in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

The effects of somatostatin in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

Genetics of Serum Dehydroepiandrosterone Sulfate and Its Relationship to Insulin in a Population-Based Cohort of Twin Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02414.X

10.1111/J.1365-2265.2005.02414.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017